Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy

被引:10
作者
Beuthien-Baumann, B
Hahn, G
Winkler, C
Heubner, G
机构
[1] Univ Hosp Carl Gustav Carus, Dept Nucl Med, D-01307 Dresden, Germany
[2] Univ Hosp Carl Gustav Carus, PET Ctr Rossendorf, D-01307 Dresden, Germany
[3] Univ Hosp Carl Gustav Carus, Sect Children, Inst Radiol, D-01307 Dresden, Germany
[4] Univ Hosp Carl Gustav Carus, Dept Radiat Therapy & Radiooncol, D-01307 Dresden, Germany
[5] Univ Hosp Carl Gustav Carus, Dept Pediat, D-01307 Dresden, Germany
关键词
anaplastic ependymoma; magnetic resonance imaging; positron emission tomography; hyperfractionated radiotherapy; radiation necrosis;
D O I
10.1007/s00066-003-1141-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In patients after treatment for malignant brain tumors, a clear distinction between tumor recurrence and radiation necrosis can be challenging. This case report describes the diagnostic workup in a child with anaplastic ependymoma and inconclusive MRI (magnetic resonance imaging) and PET (positron emission tomography) findings. Case Report: 1.5 years after resection, hyperfractionated radiotherapy and chemotherapy of an anaplastic ependymoma in the right parietal region, the cranial MRI of an 11-year-old girl showed multiple small contrast-enhanced lesions in the frontal cortex. In the following months, these lesions increased in number and size and neurologic symptoms developed. Diagnostic workup included repeated MRI scans, PET with an F-18-amino acid and F-18-fluorodeoxyglucose (FDG), as well as a brain biopsy. Results: Amino acid PET, performed when the lesions were still small, showed multiple small areas of mild uptake in close correlation to the MRI Lesions. Although not typical, this result was suspicious of tumor seeding, the more since the lesions appeared in gray matter areas outside the high-dose-rate irradiation field. A biopsy, performed 6 months later when the clinical appearance worsened, showed no tumor tissue. FDG PET, performed after the size and number of the lesions had increased, showed no intensely increased glucose metabolism, a high-grade recurrent tumor was therefore very unlikely. In the following months, the clinical picture stabilized. Conclusion: The final interpretation of the lesions was multiple focal radiation necrosis based on perfusion abnormalities after chemotherapy and conformal hyperfractionated radiotherapy, probably due to an individually enhanced vulnerability of the cerebral vessels.
引用
收藏
页码:819 / 822
页数:4
相关论文
共 22 条
[1]  
Ang KK, 1999, FRONT RADIAT THER ON, V33, P253
[2]   3-O-Methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging [J].
Beuthien-Baumann, B ;
Bredow, J ;
Burchert, W ;
Füchtner, F ;
Bergmann, R ;
Alheit, HD ;
Reiss, G ;
Hliscs, R ;
Steinmeier, R ;
Franke, WG ;
Johannsen, B ;
Kotzerke, J .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (07) :1004-1008
[3]  
CASTEL JC, 1989, J NEURORADIOLOGY, V16, P81
[4]   The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery [J].
Chao, ST ;
Suh, JH ;
Raja, S ;
Lee, SY ;
Barnett, G .
INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (03) :191-197
[5]  
CHIRO GD, 1986, INVEST RADIOL, V22, P360
[6]   CEREBRAL METABOLISM OF 6-[F-18]FLUORO-L-3,4-DIHYDROXYPHENYLALANINE IN THE PRIMATE [J].
FIRNAU, G ;
SOOD, S ;
CHIRAKAL, R ;
NAHMIAS, C ;
GARNETT, ES .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (04) :1077-1082
[7]  
FUECHTER F, 1999, J LABELLED CPD RA S1, V42, P267
[8]  
FUECHTNER F, 2003, APPL RADIAT ISOTOPES, V85, P575
[9]  
GIROLAMI UD, 1994, ROBBINS PATHOLOGIC B, P1345
[10]   DL-3-I-123-IODO-ALPHA-METHYLTYROSINE UPTAKE IN BRAIN-TUMOR RECURRENCES [J].
GUTHTOUGELIDIS, B ;
MULLER, S ;
MEHDORN, MM ;
KNUST, EJ ;
DUTSCHKA, K ;
REINERS, C .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 1995, 34 (02) :71-75